Iovance Biotherapeutics, Inc. (IOVA) CEO Maria Fardis on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/07/21
Iovance Biotherapeutics Reports First Quarter 2021 Financial Results and Corporate UpdatesGlobeNewsWire • 05/06/21
Iovance Biotherapeutics to Present Clinical Data for Lifileucel in Advanced Melanoma at ASCO 2021 Annual MeetingGlobeNewsWire • 04/28/21
Iovance Biotherapeutics to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 6, 2021GlobeNewsWire • 04/27/21
Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During American Association for Cancer Research (AACR) 2021 Annual MeetingGlobeNewsWire • 04/09/21
Why Is Iovance Biotherapeutics (IOVA) Down 21.5% Since Last Earnings Report?Zacks Investment Research • 03/27/21
Iovance Biotherapeutics to Present Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at American Association for Cancer Research (AACR) 2021 Annual MeetingGlobeNewsWire • 03/10/21
Bumble, NextEra Energy, Wheaton Precious Metals and More Monday Afternoon Analyst Calls24/7 Wall Street • 03/08/21
Iovance Biotherapeutics, Inc. (IOVA) CEO Maria Fardis on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/26/21
Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate UpdatesGlobeNewsWire • 02/25/21
Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25, 2021GlobeNewsWire • 02/18/21
Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021GlobeNewsWire • 12/28/20
Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial OfficerGlobeNewsWire • 12/14/20
Why Is Iovance Biotherapeutics (IOVA) Up 6.7% Since Last Earnings Report?Zacks Investment Research • 12/05/20